The Belgian chemical multinational UCB and Microsoft have entered into an agreement to search more efficiently for new drugs together.
The two companies report this in a press release.
UCB and Microsoft are already collaborating in the global quest for antivirals, with Microsoft technology’s computing power helping scientists work faster.
That collaboration is now being expanded to a strategic multi-year collaboration where Microsoft will provide cloud services and artificial intelligence.
In this way, UCB wants to find drugs more quickly, including for conditions other than covid-19.